Pipeline Programs↗
Distinct drugs in development (Preclinical–Phase 3)
Indications↗
Distinct diseases across all programs
Clinical Trials↗
All sponsored trials (all statuses)
Pipeline
By Phase
16 drugs in development
By Therapeutic Area
top 3
R&D Momentum
80/100
Pipeline Velocity
54/100
Trial Completion Rate
96/100
Pipeline Concentration
31/100
Pipeline Freshness
67/100
Strategic Signals
Activity
Last 14 days
Safety of Anticoagulation Therapy in Cirrhotic Patients With Portal Vein Thrombosis and Severe Thrombocytopenia as Long as Platelet Counts no Less Than 30×10^9/L
Study on the Safety and Therapeutic Effect of Peripheral Nerve Decompression Combined With Peripheral Nerve Stimulation for the Treatment of Painful Diabetic Peripheral Neuropathy
Clinical Application of an AI-based Dissection Trajectory Prediction System (ADTPS) in Endoscopic Submucosal Dissection: A Prospective Paired Diagnostic Study and a Randomized Controlled Clinical Trial
Earlier
Details
Company Overview
—
Mkt Cap
—
Revenue
—
Cash
Pipeline
Data sources: ClinicalTrials.gov (NIH) · OpenFDA (FDA) · ChEMBL (EMBL-EBI) · Open Targets (EBI/Sanger) · MedlinePlus (NIH) · PubMed (NIH) · SEC EDGAR (SEC)